SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-23-009506
Filing Date
2023-02-09
Accepted
2023-02-09 06:15:30
Documents
1
Group Members
FEI CHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea173066-13gauspice_terns.htm SC 13G 55659
  Complete submission text file 0001213900-23-009506.txt   57242
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92116 | Film No.: 23601004
SIC: 2834 Pharmaceutical Preparations

Mailing Address INFINITUS TOWER 2909, 168 HUBIN ROAD HUANGPU DISTRICT SHANGHAI F4 200021
Business Address INFINITUS TOWER 2909, 168 HUBIN ROAD HUANGPU DISTRICT SHANGHAI F4 200021 86-21-23169583
Auspice Ltd (Filed by) CIK: 0001844276 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G